| Literature DB >> 28325859 |
Kristen B Pitzul1, Sarah E P Munce2, Laure Perrier3, Lauren Beaupre4,5, Suzanne N Morin6, Rhona McGlasson7, Susan B Jaglal1,2,8.
Abstract
OBJECTIVE: The purpose of this study is to identify existing or potential quality of care indicators (ie, current indicators as well as process and outcome measures) in the acute or postacute period, or across the continuum of care for older adults with hip fracture.Entities:
Keywords: HEALTH SERVICES ADMINISTRATION & MANAGEMENT; REHABILITATION MEDICINE
Mesh:
Year: 2017 PMID: 28325859 PMCID: PMC5372037 DOI: 10.1136/bmjopen-2016-014769
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1The total number of articles yielded from the literature search in 2016, and the final number of articles included in the study. CENTRAL, the Cochrane Central Register of Controlled Trials; PEDRO, physiotherapy evidence database.
Country of study, study setting and study design, number of included studies (n, % total n)
| Number (% total*) of Studies | |
|---|---|
| Country of study | |
| Other Europe | 84 (28%) |
| UK | 81 (27%) |
| USA | 67 (22%) |
| Australia and New Zealand | 39 (13%) |
| Nordic Countries (Norway, Denmark, Finland, Sweden) | 48 (16%) |
| Canada | 28 (9%) |
| Asia | 13 (4%) |
| Middle East (Israel, India) | 8 (3%) |
| Study setting | |
| Acute | 237 (78%) |
| Postacute (any) | 24 (8%) |
| Across the continuum of care | 41 (14%) |
| Study design | |
| Retrospective cohort | 85 (28%) |
| Prospective cohort | 53 (18%) |
| Review (scoping, systematic, etc) | 50 (17%) |
| Randomised controlled trial | 34 (11%) |
| Clinical Audit | 31 (10%) |
| Experimental (eg, pre-post) | 19 (6%) |
| Population-based cohort | 9 (3%) |
| Descriptive | 7 (2%) |
| Cross-sectional | 6 (2%) |
| Focus groups/interviews/consensus meetings | 4 (1%) |
| Pilot study | 2 (1%) |
| Survey | 2 (1%) |
*The total percentage does not add up to 100% for country of study as some studies took place in multiple countries.
Number of studies (n, % total N studies), by process or outcome constructs containing indicators or potential indicators
| Construct | Indicators or potential indicators | n (%N) |
|---|---|---|
| Mortality | In-hospital mortality; postdischarge mortality (eg, 30 days, 90 days) | 125 (41%) |
| Time-to | Time from presentation to admission; time from admission to medical clearance; time from admission to surgery/surgical delay; operative time; time to rehabilitation | 106 (35%) |
| Length of stay | During acute care; during intensive care; during rehabilitation; during a readmission | 93 (31%) |
| Comorbidities and complications | Developed in-hospital; developed postoperatively; number present at admission; classification (major vs minor); adverse events in-hospital; pressure ulcers; urinary tract infections; venous thromboembolism; reoperation; infections | 86 (29%) |
| Functional ability | Activities of daily living (ADLs) or instrumental ADLs (IADLs); short physical performance battery (SPPB); functional independence measure (FIM); Barthel or Modified Barthel Index; Katz or Modified Katz; Timed up and go; Harris Hip Score; SF36; Tinetti's Fall Efficacy Scale; Berg Balance Scale; sit to stand test; Frenchay's Activity Index; Activity Measure for Post-acute care (AM-PAC); Other measures | 84 (28%) |
| Discharge destinations | Novel institutionalisation; change in premorbid level of care; discharge destination (eg, home, long-term care); successful community discharge | 64 (21%) |
| Balance and mobility | Mobile yes/no; ability (eg, walking distance); ambulation decline; balance (eg, postural sway); weight bearing | 62 (21%) |
| Quality of life (QOL) | EQ5D, EuroQOL (includes EQ5D and EQ-Visual Analog Scale); Health-related QOL (HRQOL); Dementia assessment for QOL (DEMQOL); Swedish QOL (SWED-QUAL); WHO's Brief QOL (WHOQOL-BREF); Short Form 12 (SF12), 36 (SF36) and 6D (SF6D); Western Ontario and McMaster Short Form (WOMAC-SF); Other (eg, Health Utilities Index) | 39 (13.0%) |
| Other | Organisation's performance evaluation system (130 simple indicators and 50 composite measures); day of admission; maintainability (ie, unexpected event, including deaths, readmission or change in level of care); weight; composite poor outcome (eg, death or readmission); patient safety strategies | 30 (10%) |
| Pain | Presence of pain (acute, chronic); pain score in EQ5D; assessment of pain (yes/no); use of analgesia (yes/no and type) | 29 (10%) |
| Readmissions | 15, 28 or 30 days; 2 months, 4 months, monthly; 1 year | 26 (9%) |
| Cognitive | Score or status (eg, mini mental status examination score); depression (yes/no); delirium (yes/no) | 25 (8%) |
| UK's Best Practice Tariff Indicators (BPT) | Admission under consultant-led joint orthogeriatric care; admission using a multidisciplinary assessment protocol; Geriatric-directed multidisciplinary rehabilitation; perioperative assessment by geriatrician or ortho-geriatrician within 72 hours of admission to emergency department; Admission to ward from emergency department within 4 hours; Assessment for falls and bone protection | 24 (8%) |
| Prophylaxis and blood | Antibiotic prophylaxis and anticoagulation (yes/no and type); blood loss (amount); blood transfusion (yes/no) | 23 (8%) |
| Osteoporosis testing and medication | Bone mineral density testing; medication postoperatively or at acute discharge | 21 (7%) |
| Falls | Crude count; prevention (eg, falls prevention programme); assessment for falls risk (in-hospital and postdischarge); Tinetti's fall efficacy scale; self-report falls at various time points postacute discharge | 19 (6%) |
| Healthcare usage | Costs; community services; physical therapy visits (acute and postacute); composite measures (readmission, emergency department visit) | 16 (5%) |
| Nutrition | Compliance with diet/nutrition interventions; vitamin D (amount); assessment (includes time to assessment) | 13 (4%) |
| Biometrics | Neuromuscular assessment or status; muscle strength; muscle contraction; knee specific measures | 11 (4%) |
| Catheters | Catheter yes/no; time to removal | 8 (3%) |
| Patient satisfaction | Questionnaire/interview with various questions (eg, questions about satisfaction with information provided about hospital care) | 5 (2%) |
| Caregivers | Support provided (eg, Social Support Scale); burden and stress (eg, Caregiver Strain Index) | 4 (1%) |
| Self-efficacy | Self-care ability; self-efficacy for exercise | 4 (1%) |
Construct of indicators or potential indicators, stratified by study setting (n and % total N of each construct)
| Construct | Acute (n, %N) | Postacute (n, % N) | Across the continuum (n, %N) |
|---|---|---|---|
| Mortality | 95 (76%) | 6 (5%) | 24 (19%) |
| Time-to | 93 (88%) | 0 (0%) | 13 (12%) |
| Length of stay | 65 (70%) | 8 (9%) | 20 (22%) |
| Comorbidities and complications | 60 (69%) | 2 (2%) | 24 (28%) |
| Functional ability | 51 (50%) | 22 (26%) | 25 (30%) |
| Discharge destination | 38 (59%) | 13 (20%) | 13 (20%) |
| Balance and mobility | 33 (53%) | 12 (19%) | 17 (27%) |
| Quality of life | 15 (39%) | 9 (22%) | 15 (37%) |
| Other | 26 (87%) | 0 (0%) | 4 (13%) |
| Pain | 17 (59%) | 4 (14%) | 8 (28%) |
| Readmissions | 15 (58%) | 3 (12%) | 8 (31%) |
| Cognitive | 17 (68%) | 4 (16%) | 4 (16%) |
| Best practice tariff | 24 (100%) | 0 (0%) | 0 (0%) |
| Prophylaxis and blood | 17 (74%) | 0 (0%) | 6 (26%) |
| Osteoporosis testing and medication | 16 (76%) | 2 (10%) | 3 (14%) |
| Falls | 14 (74%) | 3 (16%) | 2 (11%) |
| Healthcare utilization | 8 (50%) | 5 (31%) | 3 (19%) |
| Nutrition | 10 (77%) | 0 (0%) | 3 (23%) |
| Biometrics | 2 (18%) | 9 (82%) | 0 (0%) |
| Catheters | 6 (69%) | 0 (0%) | 2 (25%) |
| Patient satisfaction | 2 (40%) | 0 (0%) | 3 (60%) |
| Caregivers | 1 (25%) | 1 (25%) | 2 (50%) |
| Self-efficacy | 2 (50%) | 2 (50%) | 0 (0%) |